# OnCo record nct07523555 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07523555/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07523555", "NCT07523555" ;
  schema:name "Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies"@en ;
  schema:alternateName "ADAPT-HEM"@en ;
  schema:description "A phase 1/2 trial of Autologous CD19/CD22 dual-target CAR-T module in acute lymphoblastic leukaemia, non-Hodgkin lymphoma, multiple myeloma, acute myeloid leukaemia and peripheral T-cell lymphomas, run by Beijing Biotech, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07523555/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07523555> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2026-03-02" ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/peripheral-t-cell-lymphoma/> .